Jastreboff AM et al., NEJM 2022
Achieving good glycemic control in subjects with T2DM and HF is difficult, as several antihyperglycemic agents have been reported to increase the risk of hospitalization due to HF [43,44,45]
For most users, once-daily dosing is sufficient and more practical
Thats why we created the WH+ GLP-1 Strength Plan
More serious but less common risks can include: Gallbladder disease Pancreatitis Worsening of diabetic retinopathy in patients with diabetes Thyroid C-cell tumors observed in animal studies Certain conditions, medications, or risk factors may influence whether a healthcare provider thinks GLP-1s are appropriate for you, so women should review their full medical history with a qualified provider before starting therapy
Copper is an essential trace mineral, and our bodies need small amounts of it to function